7-OH Use and Treatment in Washington

7-hydroxymitragynine occurs naturally in kratom leaf at low levels, but many commercial 7-OH products are concentrated, enhanced, or otherwise processed so that exposure may be much higher than with traditional botanical kratom.

That distinction matters. FDA and DEA materials describe concentrated 7-OH products as opioid-like and potentially dangerous. FDA has warned consumers to avoid 7-OH products, and FDA has stated that 7-OH is not approved for any medical use.

People may not realize how strong these products can be because they are often sold in familiar retail settings and may be packaged like wellness products, gummies, tablets, or “botanical” products.

7-OH interacts with opioid receptors. Some users describe effects that feel more opioid-like than plain kratom leaf. Because some products are concentrated and dosing can be unclear or inconsistent, people may escalate faster than they expected.

Warning signs include:

• Taking 7-OH every day or multiple times per day.
• Redosing because the effects wear off quickly.
• Feeling anxious, restless, sweaty, achy, or unable to sleep when you try to stop.
• Spending more money than planned.
• Hiding use from family, friends, or clinicians.
• Using 7-OH to manage withdrawal from kratom, opioids, or other substances.
• Mixing 7-OH with alcohol, benzodiazepines, opioids, sleep medications, or other sedating substances.
• Feeling scared about losing access because of legal or regulatory changes.

If any of this sounds familiar, it is reasonable to seek help now rather than waiting for a crisis.

People report withdrawal symptoms such as restlessness, anxiety, irritability, body aches, fatigue, cold sweats, insomnia, stomach upset, low mood, and cravings. Experiences vary, and withdrawal may be affected by dose, product type, duration of use, other substances, and underlying mental health or medical conditions.

If you have been using high-potency 7-OH products, stopping abruptly may be difficult. A medical evaluation can help determine whether outpatient treatment is appropriate or whether a higher level of support is safer.

Medtriq’s first step is a thorough assessment. Your provider may ask:

• Which 7-OH products you use.
• How many tablets, gummies, shots, or doses you use per day.
• Whether the product label lists 7-OH, mitragynine, mitragynine pseudoindoxyl, MGM-15, MGM-16, or other alkaloids.
• How long you have been using it.
• What happens when you miss a dose.
• Whether you also use kratom leaf, kratom extract, opioids, alcohol, benzodiazepines, stimulants, or other substances.
• Whether you started 7-OH for pain, anxiety, mood, trauma symptoms, sleep, or opioid withdrawal.
• Your medical history, medications, safety concerns, and treatment goals.

The goal is to understand what level of care fits you. Some patients may be appropriate for telehealth-first outpatient treatment. Others may need more intensive care, urgent medical evaluation, or coordination with another clinician.

Possibly. Because 7-OH products can produce opioid-like effects and withdrawal, medications used in opioid-use treatment may be considered for some patients after evaluation. Published kratom-treatment literature includes case reports and case series involving buprenorphine/naloxone, but 7-OH-specific treatment evidence is still limited.

That means the provider-patient assessment matters. Your provider may discuss buprenorphine/naloxone, non-buprenorphine options, symptom-focused support, treatment for co-occurring mental health concerns, therapy availability on a limited basis, or referral to a higher level of care.

No one should have to guess alone about how to stop a potent product that has started to feel necessary.

Federal agencies have been actively reviewing and restricting 7-OH-related products. That can affect availability quickly. If a person is physically dependent, sudden loss of access may lead to withdrawal, panic, or unsafe attempts to replace the substance with something else.

If you are worried about what happens if 7-OH becomes harder to obtain, that is a good reason to seek care now. A planned treatment conversation is safer than waiting until you are forced into withdrawal.

Is 7-OH the same as kratom?

Not exactly. 7-OH is related to kratom, but concentrated 7-OH products can be very different from traditional kratom leaf. Natural kratom leaf contains 7-OH at low levels. Some commercial products contain added, enhanced, or concentrated 7-OH, which may carry different risks.

Can Medtriq help if I am taking 7-OH tablets every day?

Medtriq can evaluate daily 7-OH use and help determine what treatment options may be appropriate. Daily use, withdrawal symptoms, redosing, craving, or fear of stopping are all valid reasons to seek an assessment.

Is 7-OH addictive?

7-OH products may lead to dependence, withdrawal, and addiction-like patterns of use. FDA has reported harmful effects associated with 7-OH products, including addiction and withdrawal symptoms. A clinician can help evaluate whether your pattern meets criteria for a substance-use disorder and what treatment path makes sense.

Can Suboxone help with 7-OH withdrawal?

It may be considered in some situations, especially when the pattern looks opioid-like or overlaps with opioid use disorder. The evidence specific to 7-OH is still limited, so the decision should be made after a careful evaluation rather than assumed automatically.

What if I started 7-OH for pain?

Tell your provider. Pain is one reason people turn to kratom or 7-OH products. Treatment should look at both the substance-use pattern and the reason you started using it. Medtriq may help with substance-use treatment and coordinate with other medical care when pain is part of the picture.

What if I started 7-OH for anxiety or depression?

That is also important to discuss. Some people use 7-OH to manage emotional distress, sleep problems, trauma symptoms, or anxiety. Medtriq can evaluate mental health and substance use together so the treatment plan is not just about stopping one product, but also about helping you feel more stable.

Should I wait until 7-OH is banned before getting help?

No. If you feel dependent or worried about withdrawal, it is better to seek care before access changes suddenly. Legal changes can move quickly, and withdrawal can feel much harder when you are forced into it without a plan.

Can this be treated through telehealth?

Often, yes, but it depends on the assessment. Medtriq is telehealth-first across Washington State. Your provider will discuss whether outpatient virtual care is appropriate or whether a different level of support is safer.

• Kratom Use and Treatment
• Kratom for Chronic Pain
• Kratom and 7-OH Legal Status
• Substance Use Treatment
• Opioid Use Disorder
• Buprenorphine Treatment
• Suboxone Treatment

• FDA: Products Containing 7-OH Can Cause Serious Harm
• FDA: Hiding in Plain Sight: 7-OH Products
• DEA: Temporary scheduling announcement
• Federal Register: 7-OH Notice of Intent
• PubMed: Pharmacology comparison